Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $533.29 | 16 | 84.2% |
| Education | $99.99 | 1 | 15.8% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $317.98 | 6 | $0 (2024) |
| Janssen Biotech, Inc. | $141.86 | 3 | $0 (2024) |
| Ortho Dermatologics, a division of Bausch Health US, LLC | $59.94 | 3 | $0 (2024) |
| Lilly USA, LLC | $44.17 | 2 | $0 (2024) |
| Helsinn Therapeutics (U.S.), Inc. | $39.56 | 1 | $0 (2021) |
| Galderma Laboratories, L.P. | $29.77 | 2 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $194.81 | 5 | Janssen Biotech, Inc. ($99.99) |
| 2023 | $198.32 | 7 | ABBVIE INC. ($105.94) |
| 2022 | $200.59 | 4 | ABBVIE INC. ($179.21) |
| 2021 | $39.56 | 1 | Helsinn Therapeutics (U.S.), Inc. ($39.56) |
All Payment Transactions
17 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/15/2024 | Lilly USA, LLC | EBGLYSS (Drug) | Food and Beverage | In-kind items and services | $25.91 | General |
| Category: Immunology | ||||||
| 10/09/2024 | Ortho Dermatologics, a division of Bausch Health US, LLC | Cabtreo (Drug) | Food and Beverage | In-kind items and services | $20.76 | General |
| Category: Dermatology | ||||||
| 09/17/2024 | Galderma Laboratories, L.P. | — | Food and Beverage | In-kind items and services | $15.32 | General |
| 05/21/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $32.83 | General |
| Category: IMMUNOLOGY | ||||||
| 05/08/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Education | In-kind items and services | $99.99 | General |
| Category: Immunology | ||||||
| 10/25/2023 | Galderma Laboratories, L.P. | AKLIEF (Drug) | Food and Beverage | In-kind items and services | $14.45 | General |
| Category: ACNE | ||||||
| 09/12/2023 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $23.08 | General |
| Category: Immunology | ||||||
| 07/12/2023 | Ortho Dermatologics, a division of Bausch Health US, LLC | JUBLIA (Drug) | Food and Beverage | In-kind items and services | $17.80 | General |
| Category: Podiatry | ||||||
| 05/17/2023 | Lilly USA, LLC | TALTZ (Drug) | Food and Beverage | In-kind items and services | $18.26 | General |
| Category: Immunology | ||||||
| 05/17/2023 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $14.51 | General |
| Category: IMMUNOLOGY | ||||||
| 03/09/2023 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $91.43 | General |
| Category: IMMUNOLOGY | ||||||
| 02/20/2023 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $18.79 | General |
| Category: Immunology | ||||||
| 12/07/2022 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $29.17 | General |
| Category: IMMUNOLOGY | ||||||
| 08/30/2022 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $26.17 | General |
| Category: IMMUNOLOGY | ||||||
| 07/19/2022 | Ortho Dermatologics, a division of Bausch Health US, LLC | JUBLIA (Drug) | Food and Beverage | In-kind items and services | $21.38 | General |
| Category: Podiatry | ||||||
| 03/16/2022 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $123.87 | General |
| Category: IMMUNOLOGY | ||||||
| 10/28/2021 | Helsinn Therapeutics (U.S.), Inc. | VALCHLOR (Drug) | Food and Beverage | In-kind items and services | $39.56 | General |
| Category: ONCOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 10 | 864 | 1,700 | $211,900 | $40,955 |
| 2022 | 9 | 599 | 1,052 | $132,839 | $25,439 |
All Medicare Procedures & Services
33 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 144 | 203 | $33,056 | $9,884 | 29.9% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 133 | 165 | $29,266 | $4,845 | 16.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 43 | 64 | $15,167 | $4,160 | 27.4% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 74 | 74 | $17,188 | $3,763 | 21.9% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 89 | 103 | $31,724 | $3,679 | 11.6% |
| 17004 | Destruction of precancer skin growth, 15 or more growths | Office | 2023 | 30 | 39 | $15,052 | $3,008 | 20.0% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2023 | 49 | 59 | $14,211 | $2,914 | 20.5% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 101 | 620 | $11,129 | $1,803 | 16.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2023 | 43 | 53 | $8,522 | $1,678 | 19.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 17 | 17 | $6,119 | $1,400 | 22.9% |
| 17000 | Destruction of precancer skin growth, 1 growth | Facility | 2023 | 36 | 42 | $7,450 | $1,138 | 15.3% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Facility | 2023 | 22 | 22 | $5,068 | $994.23 | 19.6% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2023 | 20 | 27 | $4,485 | $676.47 | 15.1% |
| 17110 | Destruction of skin growth, 1-14 growths | Facility | 2023 | 15 | 16 | $3,854 | $532.08 | 13.8% |
| 11102 | Biopsy of related skin growth, first growth | Facility | 2023 | 19 | 21 | $6,468 | $273.39 | 4.2% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Facility | 2023 | 29 | 175 | $3,141 | $208.03 | 6.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 55 | 62 | $9,603 | $3,448 | 35.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2022 | 61 | 78 | $11,942 | $2,933 | 24.6% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Facility | 2022 | 49 | 49 | $10,964 | $2,130 | 19.4% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 35 | 35 | $7,832 | $2,083 | 26.6% |
| 17000 | Destruction of precancer skin growth, 1 growth | Facility | 2022 | 63 | 70 | $12,416 | $2,009 | 16.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 15 | 27 | $6,058 | $1,998 | 33.0% |
| 17004 | Destruction of precancer skin growth, 15 or more growths | Office | 2022 | 19 | 20 | $7,719 | $1,875 | 24.3% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2022 | 22 | 27 | $6,503 | $1,808 | 27.8% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2022 | 35 | 37 | $11,396 | $1,772 | 15.5% |
About Christopher Jessen, DNP
Christopher Jessen, DNP is a Family healthcare provider based in Sandy, Utah. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/05/2020. The National Provider Identifier (NPI) number assigned to this provider is 1639793649.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Christopher Jessen, DNP has received a total of $633.28 in payments from pharmaceutical and medical device companies, with $194.81 received in 2024. These payments were reported across 17 transactions from 6 companies. The most common payment nature is "Food and Beverage" ($533.29).
As a Medicare-enrolled provider, Jessen has provided services to 1,463 Medicare beneficiaries, totaling 2,752 services with total Medicare billing of $66,394. Data is available for 2 years (2022–2023), covering 33 distinct procedure/service records.
Practice Information
- Specialty Family
- Location Sandy, UT
- Active Since 06/05/2020
- Last Updated 10/21/2021
- Taxonomy Code 363LF0000X
- Entity Type Individual
- NPI Number 1639793649
Products in Payments
- SKYRIZI (Biological) $303.47
- TREMFYA (Drug) $141.86
- VALCHLOR (Drug) $39.56
- JUBLIA (Drug) $39.18
- EBGLYSS (Drug) $25.91
- Cabtreo (Drug) $20.76
- TALTZ (Drug) $18.26
- RINVOQ (Biological) $14.51
- AKLIEF (Drug) $14.45
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Doctors in Sandy
Riley Worth, Np, NP
Family — Payments: $580,482
Shelby Miller, Aprn, APRN
Family — Payments: $124,570
John Moore, Np-C, NP-C
Family — Payments: $20,946
Hosanna Clay, Msn, Aprn, Fnp-C, MSN, APRN, FNP-C
Family — Payments: $2,018
Jennifer Jenkinson, Fnp-C, FNP-C
Family — Payments: $1,843
Mrs. Diane Smith, Aprn, Fnp, APRN, FNP
Family — Payments: $1,684